Lucentis

Active Ingredient(s): Ranibizumab
FDA Approved: * June 30, 2006
Pharm Company: * GENENTECH
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Lucentis Overview

Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss. Its effectiveness is similar to that of bevacizumab.[2][3] Its rates of side effects also appear similar.[4] However, ranibizumab typi...

Read more Lucentis Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ranibizumab

Recent Lucentis Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ranibizumab
  • Injection: 0, 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lucentis: (2 results)

Sorted by National Drug Code
  • 50242-080 Lucentis 10 mg/ml Intravitreal Injection, Solution by Genentech, Inc.
  • 50242-082 Lucentis 6 mg/ml Intravitreal Injection, Solution by Genentech, Inc.

Other drugs which contain Ranibizumab or a similar ingredient: (1 result)

Related Lucentis Topics:

Avastin/ lucentis side effecis
After eye injections of avastin i was switched to lucentis. i then had 2 tia's and stopped treatment. I had been exp... 1 reply
macugen lucentis
masculen degeneration...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 August 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA